Discover GammaPod at ESTRO 2024
GammaPod? is a solution specifically designed to provide non-invasive treatment to early-stage breast cancer, with the potential to dramatically shorten the course of the treatment itself, as well as limiting the dose to the healthy tissue of the breast, the contralateral breast, the heart, and the lungs.
With GammaPod?, it is really possible usher in a new era of breast cancer treatment, thanks to a technology offering more safety and more accuracy in a single fraction.
Clinical trials on breast cancer treatment with the GammaPod system are successfully progressing.
Among the various clinical protocols used in Udine, there is a prospective study of single fraction pre-operative stereotactic radiosurgery. The results are extremely promising! Hence, ESTRO 2024 can also be the perfect opportunity for an in-depth analysis of the results of this study.
Did you attend the 14th European Breast Cancer Conference?
The Congress saw the introduction of a poster relating to a trial conducted on 49 patients, which highlighted how a single fraction pre-operative radiosurgery leads to an exceptionally high rate of major pathological responses, including complete pathological response.
Our Partners at ESTRO 2024.
Our team will be at your disposal to guide you in discovering the latest technological innovations presented by our partners.
Our Partners' Satellite Symposia.
See you in Glasgow, at booth #95 of the Scottish Event Campus!